AX-2026-00001v1
Tirzepatide · Lot TZ-2026-X9 · Nova Peptides
CRYPTOGRAPHICALLY SEALED
SHA-384: 008fca1a0f2137a8
PDF
// LAYER 1RP-HPLC 214nm (USP <621>)

Homogeneity Profiling

pass· validated in house
99.64% purity (limit ≥98%)
14.22m16.81m
PEAKRT (min)AREA %TYPE
114.2299.64MAIN COMPOUND
216.810.35999999999999943TRACE IMPURITY
This report is immutable. Any alteration breaks the cryptographic seal. Verify independently at /verify/AX-2026-00001
RESEARCH USE ONLY

All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.

LIMITATION OF LIABILITY

To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind—including but not limited to direct, indirect, special, incidental, punitive, or consequential damages—shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.